Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Glycopyrrolate Eflow® Closed System (CS) (nebulized Glycopyrrolate) in Pooled Data from Two Randomized, Double Blind, Placebo-Controlled Studies